# Nicotine Pharmacokinetics Following Use of the P4M3 Gen 2.0 E-Cigarette Compared to Smoking Cigarettes

> **NCT05383508** · NA · COMPLETED · sponsor: **Philip Morris Products S.A.** · enrollment: 36 (actual)

## Conditions studied

- Nicotine Vaping
- Nicotine
- Vaping

## Interventions

- **OTHER:** CA35
- **OTHER:** CM35
- **OTHER:** Cig

## Key facts

- **NCT ID:** NCT05383508
- **Lead sponsor:** Philip Morris Products S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-28
- **Primary completion:** 2022-06-29
- **Final completion:** 2022-08-25
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2024-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05383508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05383508, "Nicotine Pharmacokinetics Following Use of the P4M3 Gen 2.0 E-Cigarette Compared to Smoking Cigarettes". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05383508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*